Skip to content
10-K

Annual Report

ULTRALIFE CORP ULBI

0001437749-25-010360

← back to feed
Filed
Apr 1, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 24, 2025 16.63M sh
Shares Diluted FY 2024 · Dec 31, 2023 16.23M sh
Capex FY 2024 · Dec 31, 2023 $2.55M
Operating Cash Flow FY 2024 · Dec 31, 2023 $1.93M
Long Term Debt FY 2024 · Dec 31, 2023 $23.62M
Short Term Debt FY 2024 · Dec 31, 2023 $2M
Cash And Equivalents FY 2024 · Dec 31, 2023 $10.2M
Stockholders Equity FY 2024 · Dec 31, 2023 $125.33M
Current Liabilities FY 2024 · Dec 31, 2023 $23.73M
Total Liabilities FY 2024 · Dec 31, 2023 $52.85M
Current Assets FY 2024 · Dec 31, 2023 $90.2M
Total Assets FY 2024 · Dec 31, 2023 $178.28M
Eps Diluted restated FY 2024 · Dec 31, 2023 $0.44
Eps Basic restated FY 2024 · Dec 31, 2023 $0.44
Sga Expense FY 2024 · Dec 31, 2023 $22.19M
Rd Expense FY 2024 · Dec 31, 2023 $7.53M
Net Income FY 2024 · Dec 31, 2023 $7.2M
Operating Income FY 2024 · Dec 31, 2023 $9.48M
Gross Profit FY 2024 · Dec 31, 2023 $39.2M
Cost Of Revenue FY 2024 · Dec 31, 2023 $119.44M
Revenue FY 2024 · Dec 31, 2023 $158.64M